Cryoport (CYRX) Financials

$5.95 +0.05 (+0.85%)

Closing price 05/29/2025 04:00 PM Eastern

Extended Trading

$6.00 +0.05 (+0.92%)

As of 05/29/2025 07:59 PM Eastern

Annual Income Statements for Cryoport

This table shows Cryoport's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-123	-108	-45
Consolidated Net Income / (Loss)	-115	-100	-37
Net Income / (Loss) Continuing Operations	-115	-100	-37
Total Pre-Tax Income	-113	-99	-35
Total Operating Income	-131	-115	-32
Total Gross Profit	100	99	104
Total Revenue	228	233	237
Total Cost of Revenue	129	134	133
Operating Cost of Revenue	129	134	133
Total Operating Expenses	230	214	136
Selling, General & Admin Expense	149	147	120
Research & Development Expense	18	18	16
Impairment Charge	64	50	0.00
Total Other Income / (Expense), net	17	16	-3.19
Interest Expense	-14	-0.18	6.14
Interest & Investment Income	9.90	11	8.47
Other Income / (Expense), net	-6.91	5.06	-5.52
Income Tax Expense	1.28	0.24	2.24
Preferred Stock Dividends Declared	8.00	8.00	8.00
Basic Earnings per Share	($2.49)	($2.21)	($0.93)
Weighted Average Basic Shares Outstanding	49.35M	48.74M	48.99M
Diluted Earnings per Share	($2.49)	($2.21)	($0.93)
Weighted Average Diluted Shares Outstanding	49.35M	48.74M	48.99M
Weighted Average Basic & Diluted Shares Outstanding	49.91M	48.98M	48.34M

This table shows Cryoport's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-21	-1.20	-80	-21	-64	-15	-20	-7.57	-11	-7.32
Consolidated Net Income / (Loss)	-19	0.81	-78	-19	-62	-13	-18	-5.57	-9.44	-5.32
Net Income / (Loss) Continuing Operations	-19	0.81	-78	-19	-62	-13	-18	-5.57	-9.44	-5.32
Total Pre-Tax Income	-19	1.45	-78	-19	-64	-13	-18	-5.08	-7.96	-5.26
Total Operating Income	-14	-16	-79	-21	-70	-17	-18	-10	-11	-7.80
Total Gross Profit	27	25	25	22	23	24	25	27	26	26
Total Revenue	60	57	58	55	57	56	57	63	60	60
Total Cost of Revenue	32	31	32	33	34	32	32	36	34	34
Operating Cost of Revenue	32	31	32	33	34	32	32	36	34	34
Total Operating Expenses	41	42	104	43	93	41	43	37	37	34
Selling, General & Admin Expense	37	38	36	38	39	36	39	33	33	30
Research & Development Expense	4.16	4.16	4.65	4.75	4.75	5.15	4.26	3.88	4.68	3.99
Total Other Income / (Expense), net	-4.72	18	1.62	2.60	6.12	4.11	0.61	4.96	3.08	2.54
Interest Expense	0.64	-16	0.07	1.34	1.31	-4.32	1.33	1.51	1.46	1.61
Interest & Investment Income	1.43	3.06	2.81	2.60	2.62	2.85	2.65	2.47	2.68	2.49
Other Income / (Expense), net	-5.51	-1.62	-1.12	1.34	4.81	-3.06	-0.70	4.01	1.86	1.67
Income Tax Expense	0.03	0.65	0.38	0.22	-1.36	0.47	0.64	0.49	1.48	0.06
Preferred Stock Dividends Declared	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Basic Earnings per Share	($0.42)	($0.02)	($1.62)	($0.43)	($1.32)	($0.31)	($0.42)	($0.16)	($0.24)	($0.15)
Weighted Average Basic Shares Outstanding	49.35M	49.42M	49.35M	49.02M	48.74M	48.90M	48.71M	48.36M	48.99M	48.52M
Diluted Earnings per Share	($0.42)	($0.02)	($1.62)	($0.43)	($1.32)	($0.31)	($0.42)	($0.16)	($0.24)	($0.15)
Weighted Average Diluted Shares Outstanding	49.35M	49.42M	49.35M	49.02M	48.74M	48.90M	48.71M	48.36M	48.99M	48.52M
Weighted Average Basic & Diluted Shares Outstanding	49.91M	49.43M	49.41M	49.26M	48.98M	48.96M	48.88M	45.55M	48.34M	49.00M

This table details how cash moves in and out of Cryoport's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-1.06	9.75	-103
Net Cash From Operating Activities	-16	-0.76	-1.85
Net Cash From Continuing Operating Activities	-16	-0.76	-1.85
Net Income / (Loss) Continuing Operations	-115	-100	-37
Consolidated Net Income / (Loss)	-115	-100	-37
Depreciation Expense	31	27	23
Amortization Expense	1.94	2.53	2.58
Non-Cash Adjustments To Reconcile Net Income	76	71	42
Changes in Operating Assets and Liabilities, net	-10	-2.09	-32
Net Cash From Investing Activities	177	36	-60
Net Cash From Continuing Investing Activities	177	36	-60
Purchase of Property, Plant & Equipment	-20	-44	-24
Acquisitions	-1.44	-8.21	-7.17
Purchase of Investments	-51	-43	-164
Sale and/or Maturity of Investments	249	130	132
Other Investing Activities, net	0.00	0.98	3.00
Net Cash From Financing Activities	-162	-24	-39
Net Cash From Continuing Financing Activities	-162	-24	-39
Repayment of Debt	-164	-25	-3.26
Repurchase of Common Equity	0.00	0.00	-38
Other Financing Activities, net	2.79	1.48	2.05
Effect of Exchange Rate Changes	-0.02	-1.74	-1.80
Cash Interest Paid	2.69	3.40	3.63
Cash Income Taxes Paid	1.42	1.46	1.98

This table details how cash moves in and out of Cryoport's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	0.62	-1.79	-3.21	3.32	-13	-7.84	29	1.94	5.87	-6.31
Net Cash From Operating Activities	-5.48	0.45	-8.03	-3.27	2.48	-1.96	-4.05	2.77	3.65	0.98
Net Cash From Continuing Operating Activities	-5.48	0.45	-8.03	-3.27	2.48	-1.96	-4.05	2.77	3.65	1.04
Net Income / (Loss) Continuing Operations	-19	0.81	-78	-19	-62	-13	-18	-5.57	-9.44	-5.32
Consolidated Net Income / (Loss)	-19	0.81	-78	-19	-62	-13	-18	-5.57	-9.44	-5.32
Depreciation Expense	7.89	7.84	7.56	7.47	7.45	6.91	6.72	6.40	6.13	5.79
Amortization Expense	0.32	0.42	0.60	0.60	0.60	0.65	0.64	0.64	0.65	0.64
Non-Cash Adjustments To Reconcile Net Income	8.30	-7.30	70	5.31	55	5.96	6.35	3.40	9.26	7.55
Changes in Operating Assets and Liabilities, net	-3.32	-1.32	-8.07	2.25	1.63	-2.21	0.59	-2.10	-2.95	-7.62
Net Cash From Investing Activities	3.48	154	13	6.45	-15	19	34	-1.38	7.12	-5.87
Net Cash From Continuing Investing Activities	3.48	154	13	6.45	-15	19	34	-1.38	7.12	-5.87
Purchase of Property, Plant & Equipment	-5.34	-4.93	-5.42	-4.45	-12	-11	-11	-10	-8.37	-5.59
Acquisitions	-0.32	-0.46	-0.35	-0.32	-7.60	-0.23	-0.21	-0.18	-0.10	-4.61
Sale and/or Maturity of Investments	9.14	160	55	25	48	30	45	7.85	24	23
Net Cash From Financing Activities	2.01	-155	-8.76	0.51	-0.13	-25	1.15	0.07	-5.31	-0.46
Net Cash From Continuing Financing Activities	2.01	-155	-8.76	0.51	-0.13	-25	1.15	0.07	-5.31	-0.46
Repayment of Debt	-0.13	-155	-8.77	-0.11	-0.12	-25	0.01	-0.02	-1.15	-2.10
Other Financing Activities, net	2.14	0.02	0.01	0.62	-0.00	0.25	1.14	0.09	0.45	1.00
Effect of Exchange Rate Changes	0.61	-0.52	0.26	-0.38	-0.72	0.50	-2.00	0.48	0.40	-0.97
Cash Interest Paid	2.06	-0.98	1.57	0.04	1.61	0.07	1.73	0.00	1.72	0.02
Cash Income Taxes Paid	0.24	0.47	0.29	0.42	0.51	-0.15	0.67	0.43	0.70	0.56

This table presents Cryoport's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	703	958	1,039
Total Current Assets	342	535	604
Cash & Equivalents	45	46	37
Short-Term Investments	216	410	487
Accounts Receivable	46	42	44
Inventories, net	22	26	28
Prepaid Expenses	12	10	9.32
Plant, Property, & Equipment, net	89	85	64
Total Noncurrent Assets	273	338	371
Goodwill	52	108	151
Intangible Assets	170	194	191
Noncurrent Deferred & Refundable Income Taxes	0.87	0.66	0.95
Other Noncurrent Operating Assets	50	34	28
Total Liabilities & Shareholders' Equity	703	958	1,039
Total Liabilities	302	469	483
Total Current Liabilities	65	46	41
Short-Term Debt	17	0.24	0.06
Accounts Payable	27	27	28
Current Deferred Revenue	1.11	1.31	0.44
Current Employee Benefit Liabilities	13	11	8.46
Other Current Liabilities	5.91	5.66	3.85
Total Noncurrent Liabilities	237	423	442
Long-Term Debt	185	380	407
Capital Lease Obligations	1.25	0.95	0.22
Noncurrent Deferred & Payable Income Tax Liabilities	2.53	2.82	4.93
Other Noncurrent Operating Liabilities	48	39	30
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	402	489	556
Total Preferred & Common Equity	402	489	556
Preferred Stock	34	26	18
Total Common Equity	368	463	538
Common Stock	1,146	1,131	1,115
Retained Earnings	-757	-642	-543
Accumulated Other Comprehensive Income / (Loss)	-21	-26	-35

This table presents Cryoport's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	702	852	943	1,001	1,031	1,048	1,034
Total Current Assets	350	502	526	549	585	605	609
Cash & Equivalents	45	46	50	59	67	39	31
Short-Term Investments	228	381	399	406	437	484	499
Accounts Receivable	43	40	41	43	43	46	44
Inventories, net	24	24	25	29	29	26	25
Prepaid Expenses	11	11	11	12	8.62	9.96	11
Plant, Property, & Equipment, net	88	87	86	75	69	71	58
Total Noncurrent Assets	263	264	331	377	376	372	367
Goodwill	54	52	108	149	149	152	147
Intangible Assets	176	178	190	193	195	188	192
Noncurrent Deferred & Refundable Income Taxes	1.67	1.58	0.76	0.86	0.93	0.94	1.64
Other Noncurrent Operating Assets	32	31	33	34	31	31	26
Total Liabilities & Shareholders' Equity	702	852	943	1,001	1,031	1,048	1,034
Total Liabilities	283	452	471	463	486	488	478
Total Current Liabilities	61	60	49	45	40	42	41
Short-Term Debt	18	17	0.11	0.07	0.06	0.06	1.01
Accounts Payable	25	25	27	28	26	26	27
Current Deferred Revenue	1.09	1.32	1.78	1.58	0.93	1.01	0.55
Current Employee Benefit Liabilities	11	11	14	10	8.72	10	8.63
Other Current Liabilities	6.30	5.66	5.66	4.95	4.43	4.20	3.10
Total Noncurrent Liabilities	222	392	422	418	446	446	437
Long-Term Debt	185	357	380	378	408	408	406
Capital Lease Obligations	1.31	1.14	29	30	0.62	28	23
Noncurrent Deferred & Payable Income Tax Liabilities	3.53	2.65	2.41	4.71	4.66	5.11	3.04
Other Noncurrent Operating Liabilities	32	32	10	4.86	33	5.14	4.60
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	419	400	472	538	544	561	556
Total Preferred & Common Equity	419	400	472	538	544	561	556
Preferred Stock	32	30	28	24	22	20	16
Total Common Equity	386	370	444	513	522	540	539
Common Stock	1,141	1,138	1,135	1,127	1,123	1,118	1,086
Retained Earnings	-738	-739	-661	-580	-567	-548	-504
Accumulated Other Comprehensive Income / (Loss)	-16	-29	-30	-34	-34	-30	-43

This table displays calculated financial ratios and metrics derived from Cryoport's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-2.09%	-1.70%	6.59%
EBITDA Growth	-31.20%	-562.98%	-1,553.67%
EBIT Growth	-25.13%	-194.18%	-81.22%
NOPAT Growth	-13.64%	-260.95%	-78.94%
Net Income Growth	-15.23%	-166.75%	86.45%
EPS Growth	-12.67%	-137.63%	84.95%
Operating Cash Flow Growth	-2,056.27%	59.10%	-122.78%
Free Cash Flow Firm Growth	59.47%	-23.25%	-75.48%
Invested Capital Growth	-16.86%	-6.03%	5.16%
Revenue Q/Q Growth	1.00%	-1.31%	1.68%
EBITDA Q/Q Growth	30.35%	-214.40%	11.17%
EBIT Q/Q Growth	24.87%	-103.05%	1.41%
NOPAT Q/Q Growth	29.95%	-104.47%	-9.14%
Net Income Q/Q Growth	27.58%	-113.55%	87.04%
EPS Q/Q Growth	26.55%	-95.58%	85.47%
Operating Cash Flow Q/Q Growth	-95.23%	-282.41%	35.97%
Free Cash Flow Firm Q/Q Growth	-72,519.87%	13.98%	6.15%
Invested Capital Q/Q Growth	-1.71%	-13.95%	-3.73%
Profitability Metrics	-	-	-
Gross Margin	43.62%	42.59%	43.78%
EBITDA Margin	-46.01%	-34.34%	-5.09%
Operating Margin	-57.30%	-49.37%	-13.45%
EBIT Margin	-60.32%	-47.20%	-15.77%
Profit (Net Income) Margin	-50.25%	-42.69%	-15.73%
Tax Burden Percent	101.12%	100.24%	106.38%
Interest Burden Percent	82.37%	90.23%	93.77%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-24.20%	-18.90%	-5.20%
ROIC Less NNEP Spread (ROIC-NNEP)	10.38%	0.91%	3.63%
Return on Net Nonoperating Assets (RNNOA)	-1.56%	-0.17%	-1.03%
Return on Equity (ROE)	-25.76%	-19.06%	-6.23%
Cash Return on Invested Capital (CROIC)	-5.79%	-12.68%	-10.23%
Operating Return on Assets (OROA)	-16.59%	-11.03%	-3.48%
Return on Assets (ROA)	-13.82%	-9.98%	-3.47%
Return on Common Equity (ROCE)	-24.01%	-18.25%	-6.09%
Return on Equity Simple (ROE_SIMPLE)	-28.55%	-20.36%	-6.72%
Net Operating Profit after Tax (NOPAT)	-92	-81	-22
NOPAT Margin	-40.11%	-34.56%	-9.41%
Net Nonoperating Expense Percent (NNEP)	-34.58%	-19.80%	-8.84%
Return On Investment Capital (ROIC_SIMPLE)	-15.13%	-9.26%	-2.32%
Cost of Revenue to Revenue	56.38%	57.41%	56.22%
SG&A Expenses to Revenue	65.23%	62.97%	50.60%
R&D to Revenue	7.75%	7.73%	6.63%
Operating Expenses to Revenue	100.92%	91.95%	57.22%
Earnings before Interest and Taxes (EBIT)	-138	-110	-37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-105	-80	-12
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.05	1.64	1.58
Price to Tangible Book Value (P/TBV)	2.64	4.74	4.35
Price to Revenue (P/Rev)	1.68	3.25	3.58
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.72	1.71
Enterprise Value to Revenue (EV/Rev)	1.58	3.04	3.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.51	0.78	0.73
Long-Term Debt to Equity	0.46	0.78	0.73
Financial Leverage	-0.15	-0.18	-0.28
Leverage Ratio	1.86	1.91	1.80
Compound Leverage Factor	1.54	1.72	1.68
Debt to Total Capital	33.62%	43.80%	42.29%
Short-Term Debt to Total Capital	2.85%	0.03%	0.01%
Long-Term Debt to Total Capital	30.77%	43.77%	42.29%
Preferred Equity to Total Capital	5.66%	3.02%	1.90%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.72%	53.18%	55.81%
Debt to EBITDA	-1.94	-4.76	-33.72
Net Debt to EBITDA	0.55	0.94	9.60
Long-Term Debt to EBITDA	-1.77	-4.76	-33.72
Debt to NOPAT	-2.22	-4.73	-18.24
Net Debt to NOPAT	0.64	0.94	5.19
Long-Term Debt to NOPAT	-2.03	-4.72	-18.24
Altman Z-Score	-0.59	0.51	1.09
Noncontrolling Interest Sharing Ratio	6.80%	4.26%	2.38%
Liquidity Ratios	-	-	-
Current Ratio	5.29	11.73	14.79
Quick Ratio	4.76	10.94	13.88
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-22	-54	-44
Operating Cash Flow to CapEx	-81.05%	-1.72%	-7.85%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-7.15
Operating Cash Flow to Interest Expense	0.00	0.00	-0.30
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-4.14
Efficiency Ratios	-	-	-
Asset Turnover	0.28	0.23	0.22
Accounts Receivable Turnover	5.20	5.43	5.70
Inventory Turnover	5.29	4.97	6.04
Fixed Asset Turnover	2.63	3.14	4.21
Accounts Payable Turnover	4.75	4.87	4.71
Days Sales Outstanding (DSO)	70.20	67.23	64.05
Days Inventory Outstanding (DIO)	68.99	73.43	60.44
Days Payable Outstanding (DPO)	76.83	75.01	77.47
Cash Conversion Cycle (CCC)	62.37	65.66	47.01
Capital & Investment Metrics	-	-	-
Invested Capital	344	413	440
Invested Capital Turnover	0.60	0.55	0.55
Increase / (Decrease) in Invested Capital	-70	-27	22
Enterprise Value (EV)	361	709	752
Market Capitalization	385	758	850
Book Value per Share	$7.44	$9.45	$10.97
Tangible Book Value per Share	$2.94	$3.27	$3.99
Total Capital	605	870	963
Total Debt	204	381	407
Total Long-Term Debt	186	381	407
Net Debt	-58	-76	-116
Capital Expenditures (CapEx)	20	44	24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	33	33	40
Debt-free Net Working Capital (DFNWC)	294	490	563
Net Working Capital (NWC)	277	490	563
Net Nonoperating Expense (NNE)	23	19	15
Net Nonoperating Obligations (NNO)	-58	-76	-116
Total Depreciation and Amortization (D&A)	33	30	25
Debt-free, Cash-free Net Working Capital to Revenue	14.23%	14.14%	16.88%
Debt-free Net Working Capital to Revenue	128.84%	209.96%	237.44%
Net Working Capital to Revenue	121.29%	209.86%	237.41%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.49)	($2.21)	($0.93)
Adjusted Weighted Average Basic Shares Outstanding	49.35M	48.74M	48.99M
Adjusted Diluted Earnings per Share	($2.49)	($2.21)	($0.93)
Adjusted Weighted Average Diluted Shares Outstanding	49.35M	48.74M	48.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.91M	48.98M	48.34M
Normalized Net Operating Profit after Tax (NOPAT)	-47	-46	-22
Normalized NOPAT Margin	-20.55%	-19.68%	-9.41%
Pre Tax Income Margin	-49.69%	-42.59%	-14.79%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	-6.09
NOPAT to Interest Expense	0.00	0.00	-3.64
EBIT Less CapEx to Interest Expense	0.00	0.00	-9.93
NOPAT Less CapEx to Interest Expense	0.00	0.00	-7.48
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-101.68%

This table displays calculated financial ratios and metrics derived from Cryoport's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.97%	0.90%	1.01%	-13.09%	-5.13%	-7.12%	-11.12%	20.10%	6.94%	6.65%
EBITDA Growth	80.31%	21.19%	-518.58%	-1,281.29%	-2,280.38%	-4,307.46%	-270.27%	114.72%	38.81%	26.61%
EBIT Growth	70.12%	9.65%	-322.09%	-230.17%	-608.68%	-225.48%	-105.24%	52.94%	5.53%	-18.80%
NOPAT Growth	80.06%	23.17%	-332.18%	-111.86%	-533.18%	-116.70%	-249.38%	-28.47%	-31.95%	-70.52%
Net Income Growth	70.06%	106.07%	-324.89%	-238.98%	-561.18%	-149.61%	-100.01%	58.42%	96.37%	18.54%
EPS Growth	68.18%	93.55%	-285.71%	-168.75%	-450.00%	-106.67%	-82.61%	48.39%	95.80%	16.67%
Operating Cash Flow Growth	-320.79%	122.82%	-97.95%	-217.70%	-32.07%	-299.49%	42.18%	429.39%	39.79%	-88.94%
Free Cash Flow Firm Growth	367.43%	444.47%	221.72%	152.33%	23.51%	-11.13%	-174.88%	-279.07%	-59.28%	92.16%
Invested Capital Growth	-16.86%	-27.21%	-22.33%	-8.61%	-6.03%	5.14%	5.63%	9.84%	5.16%	6.11%
Revenue Q/Q Growth	5.06%	-1.62%	5.50%	-4.66%	1.96%	-1.52%	-9.23%	4.07%	-0.18%	-5.75%
EBITDA Q/Q Growth	-14.77%	86.45%	-508.10%	79.18%	-359.31%	-6.35%	-1,261.29%	141.96%	-911.86%	109.36%
EBIT Q/Q Growth	-7.74%	77.55%	-302.91%	69.35%	-225.81%	-4.90%	-215.17%	34.20%	-49.63%	33.85%
NOPAT Q/Q Growth	-7.23%	83.60%	-272.29%	69.54%	-313.22%	7.76%	-82.50%	8.97%	-41.42%	-48.71%
Net Income Q/Q Growth	-2,420.12%	101.03%	-312.75%	69.71%	-370.19%	27.71%	-229.30%	40.93%	-77.50%	42.07%
EPS Q/Q Growth	-2,000.00%	98.77%	-276.74%	67.42%	-325.81%	26.19%	-162.50%	33.33%	-60.00%	34.78%
Operating Cash Flow Q/Q Growth	-1,325.95%	105.57%	-145.79%	-231.55%	226.70%	51.68%	-246.14%	-24.08%	272.10%	114.01%
Free Cash Flow Firm Q/Q Growth	-50.74%	171.98%	72.70%	215.57%	36.55%	3.89%	25.75%	-68.93%	7.82%	-137.73%
Invested Capital Q/Q Growth	-1.71%	0.35%	-19.52%	4.74%	-13.95%	7.08%	-5.30%	7.70%	-3.73%	7.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.83%	44.80%	43.73%	39.89%	40.62%	43.21%	43.38%	43.10%	43.54%	43.69%
EBITDA Margin	-18.86%	-17.26%	-125.34%	-21.75%	-99.56%	-22.10%	-20.47%	1.60%	-3.97%	0.49%
Operating Margin	-23.40%	-28.99%	-137.56%	-38.98%	-122.02%	-30.11%	-32.15%	-15.99%	-18.28%	-12.91%
EBIT Margin	-32.65%	-31.84%	-139.50%	-36.53%	-113.62%	-35.56%	-33.38%	-9.62%	-15.21%	-10.15%
Profit (Net Income) Margin	-31.37%	1.42%	-135.40%	-34.61%	-108.96%	-23.63%	-32.19%	-8.87%	-15.63%	-8.79%
Tax Burden Percent	100.16%	55.36%	100.49%	101.15%	97.87%	103.68%	103.58%	109.68%	118.56%	101.08%
Interest Burden Percent	95.93%	-8.06%	96.59%	93.67%	97.99%	64.09%	93.09%	84.14%	86.70%	85.72%
Effective Tax Rate	0.00%	44.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-9.88%	-8.74%	-54.51%	-13.55%	-46.70%	-10.63%	-12.40%	-6.13%	-7.08%	-4.75%
ROIC Less NNEP Spread (ROIC-NNEP)	3.45%	-24.45%	-23.93%	-7.20%	-32.64%	-8.79%	-7.79%	-7.23%	-6.07%	-4.84%
Return on Net Nonoperating Assets (RNNOA)	-0.52%	3.22%	3.73%	0.88%	5.99%	1.25%	1.68%	1.64%	1.72%	1.27%
Return on Equity (ROE)	-10.40%	-5.52%	-50.78%	-12.67%	-40.72%	-9.38%	-10.73%	-4.49%	-5.36%	-3.48%
Cash Return on Invested Capital (CROIC)	-5.79%	-0.01%	-7.76%	-10.52%	-12.68%	-13.42%	-13.04%	-14.66%	-10.23%	-10.54%
Operating Return on Assets (OROA)	-8.98%	-8.46%	-33.43%	-8.26%	-26.55%	-8.26%	-7.74%	-2.24%	-3.35%	-2.55%
Return on Assets (ROA)	-8.63%	0.38%	-32.45%	-7.82%	-25.46%	-5.49%	-7.46%	-2.07%	-3.45%	-2.21%
Return on Common Equity (ROCE)	-9.69%	-5.19%	-47.95%	-12.07%	-38.98%	-9.03%	-10.38%	-4.37%	-5.23%	-3.41%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-37.86%	-43.13%	-23.91%	0.00%	-8.68%	-7.11%	-5.26%	0.00%	-51.82%
Net Operating Profit after Tax (NOPAT)	-9.75	-9.09	-55	-15	-49	-12	-13	-7.03	-7.72	-5.46
NOPAT Margin	-16.38%	-16.05%	-96.29%	-27.29%	-85.42%	-21.08%	-22.50%	-11.19%	-12.80%	-9.03%
Net Nonoperating Expense Percent (NNEP)	-13.33%	15.71%	-30.59%	-6.34%	-14.07%	-1.84%	-4.61%	1.10%	-1.01%	0.09%
Return On Investment Capital (ROIC_SIMPLE)	-1.61%	-1.46%	-7.15%	-1.69%	-5.62%	-1.25%	-1.35%	-0.71%	-0.80%	-0.55%
Cost of Revenue to Revenue	54.17%	55.20%	56.27%	60.11%	59.38%	56.79%	56.62%	56.90%	56.46%	56.31%
SG&A Expenses to Revenue	62.25%	66.45%	62.44%	70.16%	67.79%	64.15%	68.05%	52.92%	54.07%	50.01%
R&D to Revenue	6.98%	7.34%	8.07%	8.70%	8.29%	9.17%	7.48%	6.17%	7.75%	6.59%
Operating Expenses to Revenue	69.23%	73.79%	181.29%	78.87%	162.65%	73.32%	75.52%	59.09%	61.82%	56.60%
Earnings before Interest and Taxes (EBIT)	-19	-18	-80	-20	-65	-20	-19	-6.04	-9.18	-6.14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-11	-9.78	-72	-12	-57	-12	-12	1.01	-2.40	0.30
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.05	1.04	0.92	1.95	1.64	1.31	1.51	2.15	1.58	2.19
Price to Tangible Book Value (P/TBV)	2.64	2.56	2.45	5.93	4.74	3.91	4.42	5.79	4.35	5.91
Price to Revenue (P/Rev)	1.68	1.77	1.51	3.85	3.25	2.84	3.26	4.68	3.58	5.06
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.04	0.92	1.98	1.72	1.33	1.59	2.31	1.71	2.40
Enterprise Value to Revenue (EV/Rev)	1.58	1.61	1.41	3.80	3.04	2.70	2.96	4.41	3.17	4.71
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	1,535.58	212.24	2,740.69	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.51	0.49	0.94	0.87	0.78	0.76	0.75	0.78	0.73	0.78
Long-Term Debt to Equity	0.46	0.44	0.89	0.87	0.78	0.76	0.75	0.78	0.73	0.77
Financial Leverage	-0.15	-0.13	-0.16	-0.12	-0.18	-0.14	-0.22	-0.23	-0.28	-0.26
Leverage Ratio	1.86	1.78	1.99	1.93	1.91	1.86	1.87	1.82	1.80	1.54
Compound Leverage Factor	1.79	-0.14	1.93	1.81	1.87	1.19	1.74	1.53	1.56	1.32
Debt to Total Capital	33.62%	32.74%	48.41%	46.43%	43.80%	43.19%	42.91%	43.74%	42.29%	43.66%
Short-Term Debt to Total Capital	2.85%	2.82%	2.24%	0.01%	0.03%	0.01%	0.01%	0.01%	0.01%	0.10%
Long-Term Debt to Total Capital	30.77%	29.92%	46.17%	46.42%	43.77%	43.19%	42.90%	43.74%	42.29%	43.56%
Preferred Equity to Total Capital	5.66%	5.19%	3.90%	3.21%	3.02%	2.57%	2.34%	2.04%	1.90%	1.65%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.72%	62.07%	47.68%	50.36%	53.18%	54.24%	54.76%	54.22%	55.81%	54.69%
Debt to EBITDA	-1.94	-1.35	-2.45	-4.40	-4.76	-16.05	-32.04	-102.62	-33.72	-31.67
Net Debt to EBITDA	0.55	0.46	0.34	0.42	0.94	2.24	7.49	20.44	9.60	7.27
Long-Term Debt to EBITDA	-1.77	-1.23	-2.33	-4.40	-4.76	-16.04	-32.04	-102.60	-33.72	-31.60
Debt to NOPAT	-2.22	-1.56	-2.86	-4.63	-4.73	-10.37	-12.38	-18.24	-18.24	-21.05
Net Debt to NOPAT	0.64	0.53	0.39	0.44	0.94	1.45	2.89	3.63	5.19	4.83
Long-Term Debt to NOPAT	-2.03	-1.42	-2.73	-4.62	-4.72	-10.37	-12.37	-18.24	-18.24	-21.00
Altman Z-Score	-0.04	0.11	-0.19	0.90	0.66	0.83	1.01	1.56	1.17	1.67
Noncontrolling Interest Sharing Ratio	6.80%	5.91%	5.56%	4.70%	4.26%	3.71%	3.28%	2.78%	2.38%	2.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.29	5.70	8.38	10.73	11.73	12.23	14.54	14.54	14.79	14.96
Quick Ratio	4.76	5.15	7.80	10.00	10.94	11.32	13.61	13.66	13.88	14.09
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	60	122	45	26	-22	-35	-37	-49	-29	-32
Operating Cash Flow to CapEx	-102.54%	9.07%	-148.04%	-73.39%	20.71%	-17.39%	-37.73%	27.65%	43.67%	17.56%
Free Cash Flow to Firm to Interest Expense	94.22	0.00	677.63	19.35	-17.16	0.00	-27.61	-32.79	-20.12	-19.75
Operating Cash Flow to Interest Expense	-8.62	0.00	-121.59	-2.44	1.90	0.00	-3.05	1.84	2.51	0.61
Operating Cash Flow Less CapEx to Interest Expense	-17.02	0.00	-203.73	-5.77	-7.28	0.00	-11.12	-4.81	-3.24	-2.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.28	0.27	0.24	0.23	0.23	0.23	0.23	0.23	0.22	0.25
Accounts Receivable Turnover	5.20	5.25	5.42	5.18	5.43	5.43	5.53	6.09	5.70	5.63
Inventory Turnover	5.29	4.96	5.00	5.09	4.97	5.00	5.25	5.73	6.04	6.98
Fixed Asset Turnover	2.63	2.78	2.90	2.86	3.14	3.58	3.91	4.06	4.21	4.64
Accounts Payable Turnover	4.75	4.92	5.15	4.92	4.87	4.85	4.76	5.14	4.71	4.68
Days Sales Outstanding (DSO)	70.20	69.48	67.33	70.42	67.23	67.21	65.96	59.96	64.05	64.82
Days Inventory Outstanding (DIO)	68.99	73.64	72.98	71.76	73.43	73.06	69.55	63.66	60.44	52.32
Days Payable Outstanding (DPO)	76.83	74.21	70.89	74.17	75.01	75.33	76.68	71.03	77.47	77.97
Cash Conversion Cycle (CCC)	62.37	68.90	69.42	68.01	65.66	64.94	58.83	52.59	47.01	39.16
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	344	350	348	433	413	480	449	474	440	457
Invested Capital Turnover	0.60	0.54	0.57	0.50	0.55	0.50	0.55	0.55	0.55	0.53
Increase / (Decrease) in Invested Capital	-70	-131	-100	-41	-27	23	24	42	22	26
Enterprise Value (EV)	361	364	319	856	709	637	712	1,094	752	1,099
Market Capitalization	385	401	340	867	758	670	786	1,160	850	1,181
Book Value per Share	$7.44	$7.82	$7.51	$9.06	$9.45	$10.50	$11.46	$11.18	$10.97	$11.12
Tangible Book Value per Share	$2.94	$3.17	$2.82	$2.99	$3.27	$3.51	$3.90	$4.15	$3.99	$4.12
Total Capital	605	622	776	881	870	946	953	996	963	986
Total Debt	204	204	375	409	381	409	409	436	407	431
Total Long-Term Debt	186	186	358	409	381	409	409	436	407	430
Net Debt	-58	-69	-52	-39	-76	-57	-96	-87	-116	-99
Capital Expenditures (CapEx)	5.34	4.93	5.42	4.45	12	11	11	10	8.37	5.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)	33	34	32	28	33	38	40	40	40	40
Debt-free Net Working Capital (DFNWC)	294	306	460	477	490	504	545	563	563	569
Net Working Capital (NWC)	277	289	442	477	490	504	545	563	563	568
Net Nonoperating Expense (NNE)	8.93	-9.90	23	4.00	13	1.43	5.52	-1.46	1.71	-0.15
Net Nonoperating Obligations (NNO)	-58	-69	-52	-39	-76	-57	-96	-87	-116	-99
Total Depreciation and Amortization (D&A)	8.21	8.26	8.16	8.07	8.05	7.56	7.37	7.05	6.79	6.43
Debt-free, Cash-free Net Working Capital to Revenue	14.23%	14.95%	14.35%	12.57%	14.14%	16.27%	16.75%	16.34%	16.88%	17.09%
Debt-free Net Working Capital to Revenue	128.84%	135.54%	203.68%	211.90%	209.96%	213.37%	226.46%	227.25%	237.44%	244.00%
Net Working Capital to Revenue	121.29%	127.77%	195.96%	211.85%	209.86%	213.34%	226.43%	227.23%	237.41%	243.57%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.42)	($0.02)	($1.62)	($0.43)	($1.32)	($0.31)	($0.42)	($0.16)	($0.24)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	49.35M	49.42M	49.35M	49.02M	48.74M	48.90M	48.71M	48.36M	48.99M	48.52M
Adjusted Diluted Earnings per Share	($0.42)	($0.02)	($1.62)	($0.43)	($1.32)	($0.31)	($0.42)	($0.16)	($0.24)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	49.35M	49.42M	49.35M	49.02M	48.74M	48.90M	48.71M	48.36M	48.99M	48.52M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.91M	49.43M	49.41M	49.26M	48.98M	48.96M	48.88M	45.55M	48.34M	49.00M
Normalized Net Operating Profit after Tax (NOPAT)	-9.75	-9.09	-11	-15	-14	-12	-13	-7.03	-7.72	-5.46
Normalized NOPAT Margin	-16.38%	-16.05%	-18.74%	-27.29%	-24.82%	-21.08%	-22.50%	-11.19%	-12.80%	-9.03%
Pre Tax Income Margin	-31.32%	2.57%	-134.74%	-34.22%	-111.33%	-22.79%	-31.08%	-8.09%	-13.19%	-8.70%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-30.56	0.00	-1,217.41	-14.90	-49.81	0.00	-14.30	-4.00	-6.30	-3.81
NOPAT to Interest Expense	-15.33	0.00	-840.30	-11.13	-37.45	0.00	-9.64	-4.66	-5.31	-3.39
EBIT Less CapEx to Interest Expense	-38.97	0.00	-1,299.55	-18.23	-58.99	0.00	-22.37	-10.65	-12.05	-7.29
NOPAT Less CapEx to Interest Expense	-23.74	0.00	-922.43	-14.46	-46.63	0.00	-17.71	-11.31	-11.05	-6.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-101.68%	-11.58%

Frequently Asked Questions About Cryoport's Financials

When does Cryoport's fiscal year end?

According to the most recent income statement we have on file, Cryoport's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Cryoport's net income changed over the last 2 years?

Cryoport's net income appears to be on an upward trend, with a most recent value of -$114.76 million in 2024, rising from -$37.33 million in 2022. The previous period was -$99.59 million in 2023. Find out what analysts predict for Cryoport in the coming months.

What is Cryoport's operating income?

Cryoport's total operating income in 2024 was -$130.87 million, based on the following breakdown:

Total Gross Profit: $99.63 million
Total Operating Expenses: $230.50 million

How has Cryoport revenue changed over the last 2 years?

Over the last 2 years, Cryoport's total revenue changed from $237.28 million in 2022 to $228.39 million in 2024, a change of -3.7%.

How much debt does Cryoport have?

Cryoport's total liabilities were at $301.59 million at the end of 2024, a 35.7% decrease from 2023, and a 37.5% decrease since 2022.

How much cash does Cryoport have?

In the past 2 years, Cryoport's cash and equivalents has ranged from $36.60 million in 2022 to $46.35 million in 2023, and is currently $45.29 million as of their latest financial filing in 2024.

How has Cryoport's book value per share changed over the last 2 years?

Over the last 2 years, Cryoport's book value per share changed from 10.97 in 2022 to 7.44 in 2024, a change of -32.2%.

Related Companies

This page (NASDAQ:CYRX) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cryoport (CYRX) Financials

Frequently Asked Questions About Cryoport's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cryoport (CYRX) Financials

Annual Income Statements for Cryoport

Quarterly Income Statements for Cryoport

Annual Cash Flow Statements for Cryoport

Quarterly Cash Flow Statements for Cryoport

Annual Balance Sheets for Cryoport

Quarterly Balance Sheets for Cryoport

Annual Metrics And Ratios for Cryoport

Quarterly Metrics And Ratios for Cryoport

Frequently Asked Questions About Cryoport's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools